Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/06 → 8/31/08 |
Funding
- Novartis (domestic): $24,622.00
A 26 Week, Randomized, Double-Blind, Parallel-Group-Controlled, Multi-center Study To Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy In Patients With Persistent Allergic Asthma
- Miller, Beth (PI)